Prognostic Nomogram for Patients With Unresectable Pancreatic Cancer Treated With Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX: Real-world Results From a Multicenter Retrospective Study (NAPOLEON study).
暂无分享，去创建一个
M. Shimokawa | T. Otsuka | K. Mitsugi | S. Arima | T. Mizuta | T. Shirakawa | T. Honda | A. Komori | K. Nio | Hiroki Taguchi | A. Makiyama | M. Fukahori | F. Koga | N. Ureshino | Y. Ide | Y. Ueda | S. Otsu | T. Shibuki | J. Nakazawa